21.54
前日終値:
$23.50
開ける:
$23.85
24時間の取引高:
420.79K
Relative Volume:
1.77
時価総額:
$365.05M
収益:
$978.76M
当期純損益:
$-286.52M
株価収益率:
-1.2436
EPS:
-17.3212
ネットキャッシュフロー:
$-31.63M
1週間 パフォーマンス:
-3.80%
1か月 パフォーマンス:
-7.16%
6か月 パフォーマンス:
-11.07%
1年 パフォーマンス:
-69.82%
Claritev Corp Stock (CTEV) Company Profile
Compare CTEV vs VEEV, TEM, BTSG, HNGE, HQY
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
CTEV
Claritev Corp
|
21.54 | 365.05M | 978.76M | -286.52M | -31.63M | -17.32 |
|
VEEV
Veeva Systems Inc
|
318.18 | 51.52B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
TEM
Tempus Ai Inc
|
67.16 | 12.24B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
BTSG
Brightspring Health Services Inc
|
58.88 | 11.65B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
HNGE
Hinge Health Inc
|
111.71 | 9.01B | 646.34M | -512.40M | 202.76M | -6.6871 |
|
HQY
Healthequity Inc
|
103.75 | 8.58B | 1.34B | 230.70M | 440.96M | 2.6695 |
Claritev Corp Stock (CTEV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-05-29 | 開始されました | Canaccord Genuity | Buy |
| 2026-04-24 | 開始されました | Barclays | Overweight |
| 2026-01-12 | 開始されました | Guggenheim | Buy |
| 2026-01-09 | 開始されました | Wells Fargo | Equal Weight |
| 2025-10-21 | アップグレード | Citigroup | Neutral → Buy |
| 2025-05-29 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2024-06-26 | 開始されました | Piper Sandler | Neutral |
| 2022-12-13 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-07-12 | 開始されました | Goldman | Neutral |
| 2021-10-04 | 再開されました | Citigroup | Buy |
| 2021-04-07 | 開始されました | B. Riley Securities | Buy |
| 2021-03-19 | 開始されました | Barclays | Equal Weight |
すべてを表示
Claritev Corp (CTEV) 最新ニュース
Claritev Corporation Estimates – NYSE:CTEV - TradingView
Thomas Benjamin Letham Net Worth (2026) - GuruFocus
What Claritev Doubters Saw Before A 65% Fall - Simply Wall Street
MPLN5996367 Bond Profile: Coupon and Redemption - TradingView
Form 4 Claritev Corp: Jennifer Elizabeth Main (Director) For: 15 October - Investing.com Nigeria
Form 4 Claritev Corp: Jennifer Elizabeth Main (Director) For: 15 October - Investing.com India
Form 4 Claritev Corp: Jennifer Elizabeth Main (Director) For: 15 October - Investing.com UK
Jennifer Elizabeth Main Appointed to Claritev Corp Board, Reports No Stock Holdings - Kalkine Media
A director's pro-rata stock grant brings her direct holding in Claritev (CTEV) to 3,113 shares. - Stock Titan
[Form 3] Claritev Corp Initial Statement of Beneficial Ownership - Stock Titan
Claritev Corporation (CTEV) stock price, news, quote and history - Yahoo Finance Australia
Claritev (NYSE:CTEV) SVP Tiffani Misencik Sells 5,812 Shares of Stock - MarketBeat
Claritev SVP Tiffani Misencik sells $138,390 in stock - Investing.com
Form 4 Claritev Corp: Tiffani Misencik (SVP, Chief Growth Officer) For: 14 October - Investing.com Nigeria
Under a preset trading plan, Claritev Corp (CTEV)'s growth chief sells 5,812 shares. - Stock Titan
Claritev (NYSE:CTEV) Stock Has Average Target Price of $44.83 According to Brokerages - MarketBeat
Form 144 CLARITEV CORPORATION For: 15 October By Investing.com - Investing.com South Africa
Officer Tiffani Misencik proposes selling Claritev (NYSE: CTEV) shares valued at about $139K. - Stock Titan
Claritev appoints Jennifer Main to board of directors - Investing.com
Claritev Appoints Jennifer Main to its Board of Directors - GlobeNewswire
Claritev Corporation Announces Third Quarter 2026 Earnings Conference Call - StreetInsider
Claritev Corporation Announces Third Quarter 2026 Earnings Conference Call - GlobeNewswire
Claritev Corporation (CTEV) stock price, news, quote and history - Yahoo Finance UK
Should You Buy, Hold or Sell Tempus AI Stock Amid AI Boom? - Zacks Investment Research
Claritev: Revenue Growth Is Back, Cash Flow Is The Next Test (NYSE:CTEV) - Seeking Alpha
A Look at Claritev Corp (CTEV) After 11.3% Gain -- GF Value $28. - GuruFocus
Three entities report no Claritev (CTEV) shares, including a private equity investment arm. - stocktitan.net
Claritev Corp (CTEV) Shares Fall 3.7% -- What GF Score of 61 Tel - gurufocus.com
Form 144 CLARITEV CORPORATION For: 27 September By Investing.com - Investing.com Canada
Calif. Appeals Court Revives Antitrust Suit Against Claritev - Law360
Claritev Corporation (CTEV) Stock Price, News, Quote & History - Yahoo! Finance Canada
Douglas Michael Garis Sells 9,025 Shares of Claritev (NYSE:CTEV) Stock - MarketBeat
Claritev : Five Shifts Reshaping TPA Cost Management - marketscreener.com
Claritev (CTEV) CFO sells stock under pre-set plan - Stock Titan
CTEV Looks 10.5% Overvalued on GF Value™ - GuruFocus
Claritev Corporation Is Selected By General Dynamics Information Technology To Support CDC?s World Trade Center Health Program - marketscreener.com
Claritev Selected by GDIT to Support CDC’s World Trade Center Health Program - Business Wire
Planned Claritev (NYSE: CTEV) stock sale tops $278K - Stock Titan
Claritev Corporation Class A Common Stock (NYSE:CTEV) Stock Quote - The Chronicle-Journal
Claritev Corporation (CTEV) Stock Analysis: Unpacking a 44.45% Upside Potential in Healthcare Innovation - DirectorsTalk Interviews
Claritev Corp (CTEV) Stock Down 5.5% but Still Overvalued -- GF Score: 63/100 - GuruFocus
Claritev Releases 2025 Corporate Responsibility Report - Business Wire
Claritev Releases 2025 Corporate Responsibility Report - Yahoo Finance
New Claritev (CTEV) director gets 2,880-share RSU award - Stock Titan
Claritev Appoints Meta AI Research Scientist Ben Letham to Board - citybiz
Claritev Appoints Ben Letham to its Board of Directors - finance.yahoo.com
A Meta AI researcher joins Claritev’s board - Stock Titan
Claritev (NYSE:CTEV) Trading Up 4%Time to Buy? - MarketBeat
Claritev Cares Helps Rural Patients Get Critical Care Closer to Home - Stock Titan
Claritev Cares Helps Rural Patients Get Critical Care Closer to Home - finance.yahoo.com
Claritev Corp (CTEV) 財務データ
収益
当期純利益
現金流量
EPS
Claritev Corp (CTEV) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| TIFFANI MISENCIK | Officer |
Oct 15 '26 |
Proposed Sale |
23.94 |
5,812 |
139,139 |
0 |
| Douglas Garis | Officer |
Sep 21 '26 |
Proposed Sale |
30.81 |
9,025 |
278,060 |
0 |
| Garis Douglas Michael | EVP&CFO |
Sep 21 '26 |
Sale |
30.59 |
9,025 |
276,075 |
185,416 |
| Dalton Travis | Pres., CEO & Executive Chair |
Aug 28 '26 |
Buy |
38.48 |
1,950 |
75,040 |
52,322 |
| Dalton Travis | Pres., CEO & Executive Chair |
Aug 27 '26 |
Buy |
38.81 |
4,500 |
174,623 |
50,372 |
| TIFFANI MISENCIK | Officer |
Aug 14 '26 |
Proposed Sale |
40.07 |
8,850 |
354,592 |
0 |
| Misencik Tiffani | SVP, Chief Growth Officer |
Aug 14 '26 |
Sale |
40.07 |
8,850 |
354,593 |
123,723 |
| WILLIAM MINTZ | Officer |
Aug 10 '26 |
Proposed Sale |
34.24 |
8,431 |
288,677 |
0 |
| Mintz William B. | SVP, Chief Strategy Officer |
Aug 10 '26 |
Sale |
34.24 |
8,431 |
288,677 |
71,195 |
| Carol Nutter | SVP, Chief People Officer |
Jun 09 '26 |
Buy |
28.41 |
875 |
24,856 |
46,941 |
大文字化:
|
ボリューム (24 時間):